David J Propper (David Propper)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Top Venues

Nature communications

Nature reviews. Clinical oncology

British journal of cancer

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Corina E Antal, Tae Gyu Oh, Stefan Aigner, En-Ching Luo, Brian A Yee, Tania Campos, Hervé Tiriac, Katherine L Rothamel, Zhang Cheng, Henry Jiao, Allen Wang, Nasun Hah, Elizabeth Lenkiewicz, Jan C Lumibao, Morgan L Truitt, Gabriela Estepa, Ester Banayo, Senada Bashi, Edgar Esparza, Ruben M Munoz, Jolene K Diedrich, Nicole M Sodir, Jasmine R Mueller, Cory R Fraser, Erkut Borazanci, David J Propper, Daniel D Von Hoff, Christopher Liddle, Ruth T Yu, Annette R Atkins, Haiyong Han, Andrew M Lowy, Michael T Barrett, Dannielle D Engle, Gerard I Evan, Gene W Yeo, Michael Downes, Ronald M Evans
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer. Nature communications 14 (1) (2023)
David J Propper, Frances R Balkwill
Harnessing cytokines and chemokines for cancer therapy. Nature reviews. Clinical oncology 19 (4) (2022)
David J Propper, Fangfei Gao, Mark P Saunders, Debashis Sarker, John A Hartley, Victoria J Spanswick, Helen L Lowe, Louise D Hackett, Tony T Ng, Paul R Barber, Gregory E Weitsman, Sarah Pearce, Laura White, Andre Lopes, Sharon L Forsyth, Daniel Hochhauser
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer. British journal of cancer (2022)
Irene Olivera, Vicente Martín, Elixabet Bolaños, Inmaculada Rodriguez, Iñaki Etxeberría, Assunta Cirella, Josune Egea, Saray Garasa, Itziar Migueliz, Iñaki Eguren, Miguel F Sanmamed, Javier Glez-Vaz, Arantza Azpilikueta, Maite Alvarez, María Carmen Ochoa, Beatrice Malacrida, David J Propper, Carlos E De Andrea, Pedro Berraondo, Frances R Balkwill, Alvaro Teijeira, Ignacio Melero Bermejo
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β. Cancer discovery 12 (9) (2022)
Timothy J Iveson, Kathleen Anne Boyd, Rachel S Kerr, Jose Antonio Robles-Zurita, Mark P Saunders, Andrew H Briggs, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Sarah Pearson, Ashita Waterston, Louise Medley, Charles Wilson, Richard Ellis, Sharadah Essapen, Amandeep S Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David J Propper, John A Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet S Wasan, James Paul
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Health technology assessment (Winchester, England) 23 (64) (2020)
Hemant Mahendrakumar Kocher, Bristi Basu, Fieke E M Froeling, Debashis Sarker, Sarah Slater, Dominic Carlin, Nandita M deSouza, Katja N De Paepe, Michelle R Goulart, Christine Hughes, Ahmet Imrali, Rhiannon Roberts, Maria Pawula, Richard Houghton, Cheryl Lawrence, Yathushan Yogeswaran, Kelly Mousa, Carike Coetzee, Peter D Sasieni, Aaron Prendergast, David J Propper
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer. Nature communications 11 (1) (2020)